C
lonal deletion during intrathymic T cell development is one of the mechanisms that induces self-tolerance. This mechanism has been well described in mice expressing the minor lymphocyte-stimulating (Mls) gene products (1) . Mls products were initially defined by a capacity to induce a strong proliferative response in mixed lymphocyte culture between cells from H-2-compatible strains (2) . Cells reactive to Mls-1 ~ that specifically use the products of V~6, V/~8.1, and VB9 genes of the TCR were absent or highly reduced in mature T cells of Mls-1 a mice (3) (4) (5) . Until recently, the nature of the Mls antigens able to stimulate specific T cells or to induce tolerance was not known. Frankel et al. (6) have shown that Mls-1 ~ antigen is the product of an endogenous mouse mammary tumor virus (MMTV) 1 proviral loci, the Mtv-7 located on chromosome one. Strikingly, products of other endogenous or exogenous MMTV were shown to control the deletion of other specific T cell subsets (7) (8) (9) (10) (11) . Based on studies involving a large number of mouse strains, the conclusion is that the Mls-1 a phenotype, including deletion of V~6 and VB8.1 T cells, is always associated with 1Abbreviation used in this paler: MMTV, mouse mammary tumor virus. the presence of the same Mtv-7 provirus (6), and conversely, that none of the Mls-1 b strains is Mtv-7 positive (3, 4, 10) .
In the present report we described an exception to this rule showing that BALB/c, Mls-1 b mice from one colony progressively modify their T cell repertoire in an Mls-P fashion by deleting VB6 and VBS.1 T cells.
Materials and Methods
Mice. The following mice were used at different ages (8 were bred in our own facilities. BALB.D2 mice (H-2 d, I-E +, Mls-P) (13) were a gift of L. Berumen, Institut Nationale de la Sant6 et de la Recherche Mtdicale (INSERM U 267). Mice of the 13th backeross generation were used to generate a homozygous BALB.D2 congenic strain. BALB.D2, which are identical to BALB/c for H-2 expression, are maintained in a strict congenic state. B10BR (H- CellPreparation. Thymus, spleen, and peripheral lymph nodes (inguinal and axillary) were removed under sterile conditions. Cells were isolated and filtered. To isolate mature CD4 + and CD8 + cells from the thymus, total thymocytes were incubated with either anti-CD8 or anti-CD4 rat IgG antibodies for 30 rain at 4~ and then treated for another 30 min with magnetic beads coated with anti-rat lgG (Dynabeads; Dynal, Oslo, Norway). Positive cells were then removed with a magnet. For mixed lymphocyte cultures, spleen cells were depleted of CD4 + and CD8 + cells by treatment with anti-CD8 and anti-CD4 IgM rat antibodies and C'.
lmmunofluorescence. Freshly isolated cells were double labeled with FITC-labeled anti-CD4 or anti-CD8, or Jlld, and biotinylated anti-V/~ antibodies which were revealed by streptavidin-PE (Caltag Laboratories, San Francisco, CA). Flow microfluorometric analysis was performed using a FACScan | flow cytometer (Becton Dickinson and Co., Mountain View, CA). The percentage of V/~8.1 cells was defined by subtracting the percentage of F23.2 + cells from that of KJ16 + ceils.
Thymus Grafting. Newborn BALB/c thymuses were removed under sterile conditions within 24 h of birth and grafted under the kidney capsule of 36-wk-old BALB/c mice. 5 wk later, the recipients' thymus grafts, thymus, and lymph nodes were removed. CD4 § mature thymocytes were isolated as described above. Thymus and lymph node lymphocytes were then labeled with anti-CD4 and anti-V~6 antibodies.
Mixed Lymphocyte Cultures. Stimulator spleen cells were prepared from 6-and 36-wk-old BALB/c and from 8-wk-old BALB.D2-Mls-P according to the protocol of Webb et al. (22) . Spleen cells were enriched in CD8-CD4-cells (acknowledged as the best stimulators for Mls reaction), by using both anti-CD4 and anti-CD8 IgM antibodies and complement. Stimulator spleen cells were irradiated at 2,000 rad. Responder 6-wk-old thymocytes were enriched in CD4 § cells by treatment with anti-CD8 IgM antibody and C'. 5 x l0 s thymocytes and 5 x 105 irradiated spleen cells were cultured in 200/zl RPMI 1640 medium containing 1% Na Pyruvate, penicillin, and streptomycin, 10% FCS and 10 -s M 5-ME (Gibco Laboratories, Grand Island, NY). Cells were cultured for 4 d at 37"C in a 5% CO2 humidified atmosphere and were pulsed for the last 4 h with 1/zCi (37 kBq) of [3H]thymidine (sp act 1 Ci/mmol). Cells of clone F5J10 (23) (gift ofM. Bruley-R_osset, INSERM U267, Villejuif, France) (a V/36 + Mls-l' reactive cell line), were also used as responder cells, however, 2 x 104 cells were used per well.
In Vivo Tolerance Induction. BALB/c mice were injected intraperitoneally within 24 h of birth with 10 a total spleen cells after red blood cell lysis or with 25 x l& bone marrow cells. Old BALB/c spleen cells were tested before injection for V~6 expression within the CD4 + mature T cell population. Spleen cells derived from mice that had deleted VB6 were used for injection. BALKD2-Mls-P spleen and bone marrow cells were also injected. Injected newborn mice were tested 5-8 d, 11 d, or 4-5 wk later for the expression of V~6 within the CD4*CD8 -thymocyte population after depletion of CD8 + cells as aforementioned.
Genomic DNA Analysis. High molecular weight DNA was extracted from frozen spleens. DNAs (10/~g) were digested with Pvull or EcoRI restriction enzymes under reaction conditions recommended by the manufacturers. Hybridization with 3zp-labeled MMTV long terminal repeat (LTR) probe (24) was done according to standard procedures (25) . Spleen of DBA/2 (MIs.P), BALB.D2-Mls.P, and VB6-deleted or normal BALB/c were analyzed. Vfl6 expression was determined by double immunofluorescence staining using anti-CD4-FITC and biotinylated anti-V/% (clone 44-22.1). The percentage of V/36* T cells is expressed within CD4+CD8 -mature T cells, in the thymus CD4* CDS-T ceils were purified using anti-CD8 and anti-rat antibody-coated magnetic beads. BALB.D2 CD4+CD8 -thymocytes were used as a control for Mls-1, phenotype. 7 and 1%) (compared with 5-8-wk-old mice), and in the lymph nodes, two distinct groups of mice were already evident. One group had a high level of V~6 expression (10.2-13%) and the other had a low level of V~6 (1.5-4%). The mice with the lowest percentage of V~6 § thymocytes also had the lowest percentage of VB6 + cells in the lymph node. These results suggested that 14-19owk-old mice undergo a "crisis" that affects most, if not all, thymuses and leads to partial or total deletion of Vfl6 + cells. Subsequently, some of the mice then appear to recover from this crisis and contain normal levels of V~6 + cells in the thymus, spleen, and lymph nodes between 27 and 43 wk of age.
Results

Age
As for Mls-1 a mice, deletion of Vfl6 in BALB/c aging mice is associated with VB 8.1 deletion, and expression of Vfl 8.2 is not modified ( Table 1) . Expression ofV~6, VB 8.1, and VB 8.2 was also tested in seven other Mls-1 b strains (with or without I-E expression) between 27 and 43 wk of age (CBA/Ca, B10 BR, C57BL/6, C3H/HeJ, A/J, SJL/J, and B10D2). None of them showed an Mls-P-like ddetion during aging. VB14 + ceils that are deleted by exogenous MMTV in C3H/HeJ mice (9) were not ddeted in BALB/cdeleting Vfl6 + cells (data not shown).
V~6 Deletion in Thymocyte Subpopulations of Aging BALB/c
Mice. J11d labeling was used to discriminate immature (Jlld +) from mature (Jlld-) thymocytes (Table 2 ). In 5-8-wk-old mice, 8.6% Jlld-thymocytes, which contain mature thymocytes, expressed high levels of V~6. Within immature Jlld +, two subpopulations could be identified, expressing low or high levels of VB6 (V/36 l~ and v~6high).
In aging mice, those that delete V/~6hig h Jlld-, mature T ceils also delete the small fraction of Jlld + V~6his h immature thymocytes. The percentage ofJlld § VB6 l~ immature calls was the same in 5-8-wk-old and normal, or modified 27-43-wk-old mice. Fig. 2 shows that when Jlld-V/36 + Table 1 .
Repertoire of Thymus and Lymph Node BALB/c CD4+CD8 -and CD4-CD8 + T Cells as a Function of Age
Mice with nondeleted VB6
Mice with deleted VB6 and Jlld + V~6 high cells were deleted, VB 8.2 § cells were not modified compared with a normal young BALB/c mouse.
Deletion was also compared within mature CD4 § and CD8 + T cell subsets. As shown in Table 1 , CD4 + cells were more extensively deleted than CD8 § cells in the lymph nodes, and to a lesser degree in the thymus. (Table 3) . A VB6 +, Mls-P-reactive cell line (done F5J10) (23), was not reactive to BALB/c Vf36-deleted spleen cells.
Mls-la-like
The presence of Mls-l'-like antigen was also tested in vivo, in an attempt to induce a V156 clonal deletion by injecting spleen cells of VB6-deleted BALB/c aging mice into newborn BALB/c. Injection of BALB.D2.MIs-P spleen cells was used as a positive control. As shown in Table 4 , clonal deletion can be induced by the injection of BALB.D2 spleen cells, but not by the injection of VB6-deleted BALB/c spleen cells.
Newborn Thymuses Grafted into Old Mice Behave Like Their
Recipients.for V~6 Expression. Newborn BALB/c thymuses were grafted under the kidney capsule of 36-wk-old unmanipulated BALB/c recipients. Host and graft cells cannot be traced in that system. We know, however, from previous experiments using newborn thymus grafts of C57B16/Ka (Thy-1.2) into normal adult C57B16/Ba (Thy-l.1), that after 5 wk, all T cells in the recipient thymus, spleen, and lymph nodes, and in the thymus graft, were of host origin (unpublished data). In the present experiments, we tested V/36 expression by mature CD4+CD8 -cells in the thymus and lymph nodes of the host and in the grafted thymus 5 wk after grafting (Table 5) . Newborn thymuses that developed in old mice behaved like their host in their V/36 expression. Vj36 was deleted in the grafted thymus if it was deleted in the recipient's CD4+CD8 -cells. Adult BALB/c thymus and newborn grafts are both colonized by the same bone marrow cells of the host. The hypothesis was therefore tested that bone marrow cells may be modified in aging BALB/c in such a way that they were able to induce Vg/6 deletion in the newborn grafted thymuses. As shown in Table 4 , this was not the case. Tolerance to Mls-1 ~ antigen can be induced by the injection of BALB.D2.Mls-1 ~ bone marrow cells but cannot be obtained by the injection of bone marrow cells from V/~6-deleted aging BALB/c mice.
Mtv-7 Provirus Is Not Present in BALB/c with VB6 + Cell
Deletion. BALB/c mice were examined for endogenous Mtv distribution using EcoRI and PvulI digested DNAs. Whereas an expected 2.3-kb PvulI fragment Mtv-7 (26) was observed in DBA/2 and BALB.D2 DNAS, no fragment corresponding to the Mtv-7 locus was detected in DNA of VB6-deleted BALB/c. Old BALB/c recipients, 36-wk-old, were grafted with newborn thymuses under their kidney capsules. 5 wk later, thymus and lymph nodes of the recipients and thymus grafts were removed. CD4+CDS-cells of the thymuses were enriched as described in Materials and Methods, and both thymocytes and lymph node cells were double labeled with anti--CD4 and anti-Vfl6 antibodies. The percentages of Vfl6+ cells are expressed within CD4 § lymph node and thymic cells. Results are given for two Vfl6-deleted and two Vfl6 nondeteted recipients.
Discussion
We show in the present report that BALB/c Mls-1 b mice progressively modify their T cell repertoire in an Mls-1 a fashion, although the expression of Mls-lqike antigen cannot be demonstrated.
In a group of mice tested between 27 and 43 wk of age, 50% of them had deleted both T cells using the Vfl6 and the Vfl8.1 chains of the TCR, like their BALB.D2 Mls-1 ' congenic partners. Deletion affects the mature T cells in the thymus and the peripheral lymphoid organs, spleen, and lymph nodes. In the thymus, deletion occurs at the level of immature Jlld + thymocytes, within the small subset of cells expressing a high level of Vfl6. They likely correlate with the generative compartment of CD4 + CD8 + thymocytes which have already been shown to be the target for self-reactive thymocyte deletion (4, 27, 28) . These results suggest that the process of donal deletion in the BALB/c-MLS-1 b mice affects the thymus at the stage of the developing thymocytes as previously shown for Mls-P mice (4, 28) . Within the mature T cell compartment, CD4+CD8 -cells were more affected by this deletion than were CD4-CD8 + cells. This has already been shown for the deletion of Vfl3 + T cells in Mls-2 ' mice (29), although Vfl6 deletion in Mls-1 ' mice was shown to equally affect both CD4 + and CD8 + (1, 4) . In the case of Vfl6 deletion in BALB/c-MIs-1 b mice, it is possible that a small percentage of CD4 +CD8 + Vfl6hig h cells that escape deletion is able to give rise to mainly CD4-CD8 + Vfl6 § cells able to migrate to the periphery.
Deletion of Vfl6 + T cells is a progressive, age-dependent phenomenon. This is also the case for the deletion of Vfl6 + T cells in Mls-1 9 mice, where tolerance is not complete before several days after birth (30) , for Vf114 deletion in milktransmitted infection by MMTV (9), and for mice transgenic for this virus (11) . In the case of BALB/c mice, the percentage of Vfl6 § cells in the thymus is very high during the two first weeks of life (between 16 and 19% of CD4 § -cells). This percentage is considerably higher than what has been published elsewhere for young BALB/c (30) . Enhance-ment of V36 expression may be interpreted as an initial stimulation of Vfl6 + cells previous to clonal deletion, as has already been shown for the induction of tolerance to Mls-1 ~ (31). This hypothesis is currently under investigation. In young adults (5-8-wk-old), the percentage of V36 + cells is lower, however with a wide range in the thymus, lymph nodes (Fig.  1) , and spleen (data not shown). During a transitional period (14-19 wk) , there appears to be a crisis in the thymus, and virtually all thymuses seem to be involved in the process of reducing V36 expression. However, during the same transitional period, lymph nodes segregate dearly into two groups which were or were not deleted. This may indicate that the antigen involved in the clonal deletion is located primarily in all the thymuses, where it may affect developing thymocytes in different proportions in individual mice. The fact that some of the mice appear to further recover normal levels of V36 + T cells in their thymuses, and have normal expression of V36 in their lymph nodes and spleen, is unique from what has been previously described for all clonal deletion where all mice were modified. Among seven different Mls-1 b strains tested, BALB/c (males and females) was the only one to delete V36 and V38.1 with aging. In particular, B10.D2 with the same H-2 haplotype and I-E expression did not show the same deleting pattern, which excludes the possibility that the absence of deletion in the other aging mice was linked to nonpermissive MHC, as was described for the MHC control of Mls-1 ~ tolerance (4) .
The nature of the antigen involved in this process is not known. As the phenotype of aging BALB/c mice was Mlsl~-like, we tested whether an Mls-l~-like antigen was detectable in V36-deleted mice. Mixed lymphocyte cultures were done between irradiated spleen cells from V36 + T celldeleted BALB/c and CD4+CD8 -thymocytes from young BALB/c with normal VB6 expression, or the Mls-l~-specific T cell line. Although these cells respond appropriately to Mls-I a antigen on BALB.D2-Mls-1 ~ spleen cells, Mls-l~-like antigen could not be detected on the cells from V36-deleted BALB/c mice. The hypothesis that Mls-l~-like antigen could not be detected because BALB/c cells were not permissive for the presentation of Mls-1 ~ antigen is unlikely, as BALB.D2 (which properly present Mls-1 ~) and BALB/c mice are maintained in strict congenic state and were H-2 identical (13) . Furthermore, the ability of an antigen to induce clonal deletion in vivo and to stimulate the specific T cells in vitro is not always concurrent. This is true for the products of Mls-3 ~, Mls-1 ~, or I-E which induce deletion of V33, 5, 9, or 11 positive T ceils in vivo, but are not able to induce their stimulation in vitro (5, 29, 32) . As shown by Pitcher et al. (33) in transgenic mice, the quality of the antigen and a low-avidity receptor interaction may account for these results. This may also be the case for the new Mls-l~-like antigen in BALB/c mice which can induce clonal deletion in vivo, but not stimulated V36 + T cells in vitro. In that case, it is difficult to explain why the injection of BALB/c VB6-deleted spleen cells into newborn BALB/c could not induce V36 donal deletion as does the injection of congenic BALB.D2 Mls-1 ~ spleen cells. Maybe the tolerogenic antigen is not (or is no more) in the spleen of V/36-deleted BALB/c. However, it is clear from our grafting experiments that the tolerogenic antigen is still present in the old mice, which have deleted V36 + and V38.1 + T cells. This is depicted in Table 5 which shows that newborn thymuses grafted into old mice behave like the recipient's thymus. After 5 wk in situ, CD4+CD8 -VB6 + cells of the grafted thymus are deleted when they are deleted in the recipient's thymus. As recipient and grafted thymuses are both seeded by the recipient's bone marrow, we tried to induce VB6 clonal deletion in newborn mice by injecting bone marrow cells. Clonal deletion could be obtained with BALB.D2 but not with Vf6-deleted BALB/c bone marrow cells (Table 4 ). One possibility is that clonal deletion may be induced in newborn grafted thymuses by activated T cells migrating from the recipients into the grafts. These T cells have been shown by Agus et al. (34) to be the only ones to efficiently migrate back to the thymus, and are proposed to participate in the self-tolerance induction process. This may be possible if cells activated by the antigen are still present in old BALB/c. The antigen may also be expressed by thymic stromal cells or B cells. This study is now in progress.
It is therefore clear that the antigen involved is not identical to Mls-1 ~ which is the product of the Mtv-7 provirus in Mls-1 ~ mice (6) , and which is mainly presented by CD4-CD8-spleen cells (22) . Indeed we have verified that the Mtv-7 provirus easily identified as a 2.3-kb PvulI fragment in DBA/2 and BALB.D2-Mls-1 ~ mice DNA was not present in the genome of this BALB/c colony. The epidemiology of the phenomenon in aging BALB/c, which is progressive, seems more or less to affect all thymuses at "~ 14-19 wk of age, after which part of them recover, which is compatible with an infectious process. This may be the replication of an endogenous virus, the transmission of an exogenous one, as shown for milk-transmitted MMTV in C3H mice which delete V314 + T cells (9) , or be linked to a nonviral type of infection and antigen(s) (V314 is not deleted in our BALB/c colony). Genetic studies that are now in progress and the use of foster mothers to check for milk-transmitted virus will help to answer these questions. Two other colonies of BALB/c mice have also been tested: one colony in Belgium tested by A. M. Rongy in the laboratory of J. Boniver in Liege, and one colony in Australia, tested by C. Tucek in the laboratory of R. Boyd. The fact that mice from these two colonies do not delete V/36 while aging strengthened the exogenous infectious origin of this clonal deletion.
This new VB-deleting factor in BALB/c mice of this particular colony behaves like the product of other retroviruses or bacterial superantigens. It suggests that clonal deletion is a more common phenomenon than expected, which may occur each time a new retrovirus or other superantigen confronts the immune system. It may benefit the mice that in this manner escape autoreactivity or the expansion of retroviruses, by limiting their number and possible activation of their target cells by deletion and/or anergy. Conversely, it may be detrimental, by limiting recognition of certain specific and pathogenic antigens, or lead to acquired immunodeficiency when the deletion is polyclonal.
